Correction: Hsa_circ_0021727 (circ-CD44) promotes ESCC progression by targeting miR-23b-5p to activate the TAB1/NFκB pathway.

IF 9.6 1区生物学 Q1 CELL BIOLOGY Cell Death & Disease Pub Date : 2025-02-27 DOI:10.1038/s41419-025-07437-y

Fan Meng, Xiaokang Zhang, Yanting Wang, Jie Lin, Yulin Tang, Guisheng Zhang, Binqiang Qiu, Xingdu Zeng, Weiyou Liu, Xin He

引用次数: 0

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

更正：Hsa_circ_0021727 （circ-CD44）通过靶向miR-23b-5p激活TAB1/NFκB通路促进ESCC进展。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Cell Death & Disease CELL BIOLOGY-

CiteScore

15.10

自引率

2.20%

发文量

935

审稿时长

2 months

期刊介绍： Brought to readers by the editorial team of Cell Death & Differentiation, Cell Death & Disease is an online peer-reviewed journal specializing in translational cell death research. It covers a wide range of topics in experimental and internal medicine, including cancer, immunity, neuroscience, and now cancer metabolism. Cell Death & Disease seeks to encompass the breadth of translational implications of cell death, and topics of particular concentration will include, but are not limited to, the following: Experimental medicine Cancer Immunity Internal medicine Neuroscience Cancer metabolism